Sumpatan, Noralyn T.

HRN: 23-18-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2023
CEFUROXIME 1.5GM (VIAL)
06/19/2023
06/21/2023
IV
1.5gms
Q8hrs
Meconium Stained Amniotic Fluid; Leucocytosis
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: